Analysis of the Interaction between the HIV-Inactivating Protein Cyanovirin-N and Soluble Forms of the Envelope Glycoproteins gp120 and gp41
- 1 November 2000
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 58 (5), 982-992
- https://doi.org/10.1124/mol.58.5.982
Abstract
The novel virucidal protein cyanovirin-N (CV-N) binds with equally high affinity to soluble forms of either H9 cell-produced or recombinant glycosylated HIV-1 gp120 (sgp120) or gp160 (sgp160). Fluorescence polarization studies showed that CV-N is also capable of binding to the glycosylated ectodomain of the HIV-envelope protein gp41 (sgp41) (as well as SIV glycoprotein 32), albeit with considerably lower affinity than the sgp120/CV-N interaction. Pretreatment of CV-N with either sgp120 or sgp41 abrogated the neutralizing activity of CV-N against intact, infectious HIV-1 virions. Isothermal calorimetry and optical biosensor binding studies showed that CV-N bound to recombinant sgp120 with a Kd value ranging from 2 to 45 nM and to sgp41 with a Kd value of 606 nM; furthermore, they indicated an approximate 5:1 stoichiometry for CV-N binding to sgp120 and a 1:1 stoichiometry for CV-N binding to sgp41. Circular dichroism studies additionally illuminated the binding of CV-N with both sgp120 and sgp41, providing the first direct evidence that conformational changes are a consequence of CV-N interactions with both HIV-1 envelope glycoproteins.Keywords
This publication has 34 references indexed in Scilit:
- On the Meaning of Affinity: Cluster Glycoside Effects and Concanavalin AJournal of the American Chemical Society, 1999
- Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swappingJournal of Molecular Biology, 1999
- The HIV-Inactivating Protein, Cyanovirin-N, Does Not Block gp120-Mediated Virus-to-Cell BindingBiochemical and Biophysical Research Communications, 1998
- Solution structure of cyanovirin-N, a potent HIV-inactivating proteinNature Structural & Molecular Biology, 1998
- HIV Entry and Its InhibitionCell, 1998
- Construction and Enhanced Cytotoxicity of a [Cyanovirin-N]-[PseudomonasExotoxin] Conjugate against Human Immunodeficiency Virus-Infected CellsBiochemical and Biophysical Research Communications, 1997
- HIV-1 Membrane Fusion Mechanism: Structural Studies of the Interactions between Biologically-Active Peptides from gp41Biochemistry, 1996
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression systemBiochemistry, 1993
- Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural networkProtein Engineering, Design and Selection, 1993